Shareholders’ Equity - Schedule of Warrant Activity (Details) - Warrant [Member] - $ / shares |
12 Months Ended | |
|---|---|---|
Dec. 31, 2025 |
Dec. 31, 2024 |
|
| Schedule of Warrant Activity [Line Items] | ||
| Number of warrants, warrants outstanding beginning | 12,053 | |
| Weighted average exercise price per share, warrants outstanding beginning | $ 298.69 | |
| Weighted average life, warrants outstanding beginning | 5 years | 5 years |
| Expiration dates, warrants outstanding beginning | Jan. 02, 2029 | Jan. 02, 2029 |
| Number of warrants, warrants outstanding ending | 12,053 | |
| Weighted average exercise price per share, warrants outstanding ending | $ 298.69 | |
| Weighted average life, warrants outstanding ending | 5 years | 5 years |
| Expiration dates, warrants outstanding ending | Jan. 02, 2029 | Jan. 02, 2029 |
| X | ||||||||||
- Definition Represent the expiration dates, warrants outstanding. No definition available.
|
| X | ||||||||||
- Definition The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Weighted average remaining contractual term for equity-based awards excluding options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|